Hesketh, P J <br/><br/>
Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 1999 
 - 338-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1999.17.1.338  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiemetics--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Benzene Derivatives--adverse effects<br/>Cisplatin--adverse effects<br/>Dexamethasone--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Granisetron--therapeutic use<br/>Humans<br/>Male<br/>Middle Aged<br/>Neurokinin-1 Receptor Antagonists<br/>Vomiting--chemically induced